Search results
Results From The WOW.Com Content Network
Ponazuril (), sold by Merial, Inc., [1] now part of Boehringer Ingelheim, [2] under the trade name Marquis (15% w/w ponazuril), is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by coccidia Sarcocystis neurona.
On December 30, 2016 Boehringer Ingelheim completed a swap of their OTC business for Sanofi's animal health business. Merial is now owned by Boehringer Ingelheim and combined with their animal health business, Boehringer Ingelheim Vetmedica, to form Boehringer Ingelheim Animal Health.
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies , and the largest private one.
And Boehringer Ingelheim is making it available to all Americans, regardless of insurance status," Gemmell said. Cyltezo will sell for $550, a 92% discount from the Humira list price of about $7,000.
The National Research Centre on Equines (NRCE) was established during 7th five-year plan under the aegis of Indian Council of Agricultural Research for research on equine health and production considering the importance of equines in India.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
Professional Association of Therapeutic Horsemanship International (PATH Intl.), formerly the North American Riding for the Handicapped Association (NARHA), is a non-profit organization based in Denver, Colorado, that promotes the benefits of therapeutic horseback riding and other equine-assisted activities and therapies for people disabilities. [1]
A horse will not be athletically useful following a DDFT tenotomy, with a best-case scenario of the animal returning to pasture soundness or possibly for comfortable enough for light pleasure riding. It is therefore considered a salvage procedure to improve the quality of life of the horse, often as final effort to avoid euthanasia. [124]